Triatomic Management LP - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 40 filers reported holding THE ONCOLOGY INSTITUTE INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Triatomic Management LP ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$1,266,565
+154.5%
904,6890.0%0.88%
+71.6%
Q2 2023$497,579
-9.4%
904,689
+11.7%
0.51%
+38.2%
Q1 2023$549,197
-35.7%
810,145
+56.6%
0.37%
-48.6%
Q4 2022$853,840
-49.6%
517,479
+41.5%
0.72%
-26.2%
Q3 2022$1,693,000
-8.5%
365,6790.0%0.97%
-42.8%
Q2 2022$1,850,000
-39.4%
365,679
-14.6%
1.70%
-31.4%
Q1 2022$3,052,000
-21.7%
428,100
+7.0%
2.48%
+3.7%
Q4 2021$3,900,000400,0002.39%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q3 2022
NameSharesValueWeighting ↓
Parian Global Management LP 444,244$3,167,0006.52%
Velan Capital Investment Management LP 600,000$4,278,0003.97%
Triatomic Management LP 428,100$3,052,0002.48%
Empery Asset Management, LP 70,733$504,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,296,107$32,137,0000.72%
Redmile Group, LLC 2,414,432$17,215,0000.54%
Alpine Global Management, LLC 81,902$584,0000.07%
Saba Capital Management, L.P. 400,000$2,852,0000.04%
ExodusPoint Capital Management, LP 106,505$759,0000.01%
FMR LLC 12,000,000$85,560,0000.01%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders